Clinical Trials Logo

Clinical Trial Summary

This study will evaluate acupuncture's effect of preventing vasospasm after SAH.

A total of 80 participants will be recruited and will be randomized to a study group or a control group. Acupuncture, electroacupuncture and intradermal acupuncture will be done at every session in a study group, while mock transcutaneous electrical nerve stimulation(mock TENS) and sham intradermal acupuncture will be carried out in a control group.


Clinical Trial Description

Intervention starts within 96hours after SAH, after ruptured aneurysms have been secured by endovascular coiling or surgical clipping. Intervention is applied once a day, 6 days a week for 2 weeks(total 12 sessions) in addition to standard treatment such as prophylactic HHH therapy and nimodipine. Sterile disposable, stainless steel acupuncture needles are used.

Primary outcome measurement is the occurrence of delayed ischemic neurological deficit between the study group and the control group. Moreover, the incidence of angiographic vasospasm, TCD vasospasm, and vasospasm-related infarct on CT or MRI, the change of nitric oxide(NO) and endothelin-1 in plasma, mortality and participant's functional status using mRS will be compared. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02275949
Study type Interventional
Source Kyung Hee University Hospital at Gangdong
Contact
Status Completed
Phase N/A
Start date September 2014
Completion date June 2017

See also
  Status Clinical Trial Phase
Completed NCT02389634 - Identification of Novel Molecular Markers for Vasospasm
Completed NCT00962546 - Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage N/A
Not yet recruiting NCT04512859 - Stellate Ganglion Block in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage N/A
Completed NCT01024972 - Safety Study of Dantrolene in Subarachnoid Hemorrhage Phase 1/Phase 2
Completed NCT00692744 - Quality of Life in Elderly After Aneurysmal Subarachnoid Hemorrhage (SAH) N/A
Completed NCT04208477 - "The Effect of Stellate Ganglion Block in Severe Brain Injury" N/A
Recruiting NCT06303349 - Predictive Model for the Occurrence of Cerebral Vasospasm Complicating Subarachnoid Haemorrhage by Combined Analysis of the Kinetics of a Panel of Biomarkers. N/A
Recruiting NCT02129413 - Safety Study of Carotid Body Neurostimulation to Treat Cerebral Vasospasm N/A
Terminated NCT00487461 - Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage N/A
Terminated NCT00582868 - Use of Brain Oxygen Tension Level and Cleaved-tau Protein to Detect Vasospasm After SAH N/A
Withdrawn NCT01878136 - Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage Phase 1/Phase 2
Withdrawn NCT01091870 - Sildenafil for Prevention of Cerebral Vasospasm Phase 2
Completed NCT03214705 - Role of CT Perfusion in Predicting Poor Outcome After Subarachnoid Hemorrhage
Recruiting NCT05150002 - Cervical Spinal Cord Stimulation in Patients With Cerebral Vasospasm After Subarachnoid Haemorrhage: VasoStim Study N/A
Completed NCT01187420 - Bilateral Bispectral Index (BIS) Study N/A
Enrolling by invitation NCT05230134 - Cervical Sympathetic Block in Patients With Cerebral Vasospasm N/A
Withdrawn NCT02426827 - Cervical Spinal Cord Stimulation in Cerebral Vasospasm N/A
Withdrawn NCT00871065 - Safety Study of Sildenafil in Treatment of Cerebral Aneurysm Vasospasm Phase 2
Recruiting NCT04691271 - Stellate Ganglion Block and Cerebral Vasospasm N/A
Recruiting NCT02432157 - Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage: Phase 1/Phase 2